Compare Stocks: XTLB vs. ERNA vs. CANF vs. MLEC
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
XTLBERNACANFMLEC
Market Snapshot
Current market context for the selected companies.
XTLB
$2.58
Market Cap
$6.39M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
ERNA
$4.88
Market Cap
$5.74M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
CANF
$3.32
Market Cap
$7.11M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
MLEC
$6.81
Market Cap
$5.21M
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-26
Performance
Absolute returns and relative performance versus SPY.
| Metric | XTLB | ERNA | CANF | MLEC |
|---|---|---|---|---|
| 1 Month | -12.8% | +35.2% | +5.1% | -6.3% |
| 1 Month vs SPY | -16.2% | +31.9% | +1.7% | -9.6% |
| 3 Months | +5.7% | -56.2% | -0.9% | -6.1% |
| 3 Months vs SPY | +3.7% | -58.2% | -2.9% | -8.1% |
| 6 Months | -19.4% | -32.7% | -27.7% | -57.8% |
| 6 Months vs SPY | -29.8% | -43.1% | -38.1% | -68.2% |
| 1 Year | -47.6% | -86.3% | -74.5% | -70.3% |
| 1 Year vs SPY | -66.7% | -105.5% | -93.6% | -89.5% |
| 2 Years | -77.5% | -99.3% | -92.8% | -94.8% |
| 2 Years vs SPY | -114.1% | -135.8% | -129.4% | -131.4% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.